DisCoVisc Versus DuoVisc, Healon5 and AmVisc Plus

PHASE4CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

April 30, 2009

Conditions
Cataract
Interventions
DEVICE

DisCoVisc

Use of DisCoVisc Ophthalmic Viscosurgical Device (4% sodium chondroitin sulfate, 1.65% sodium hyaluronate) during cataract surgery.

DEVICE

DuoVisc

Use of DuoVisc viscoelastic system consisting of Viscoat (3% sodium hyaluronate, 4% chondroitin sulfate)and Provisc(1% sodium hyaluronate) during cataract surgery.

DEVICE

Healon5

Use of Healon5 ophthalmic viscosurgical device (2.3% Sodium Hyaluronate) during cataract surgery.

DEVICE

Amvisc Plus

Use of Amvisc Plus ophthalmic viscosurgical device (1.6% Sodium Hyaluronate) during cataract surgery.

Trial Locations (1)

76134

Contact Alcon Call Center for Study Locations, Fort Worth

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00712244 - DisCoVisc Versus DuoVisc, Healon5 and AmVisc Plus | Biotech Hunter | Biotech Hunter